SCHEMBL30037992

SCHEMBL30037992

COc1ncncc1C1C[C@@H](O)CN1C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ PIK3CD O00329 7/20 0.35
▸ GPR119 Q8TDV5 6/20 0.35
▸ SSTR4 P31391 2/20 0.34
▸ CHRM2 P08172 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ RIPK1 Q13546 1/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ PIK3CG P48736 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29305267 1.00 CYP1A2 (0.38) CYP1A2POLBCYP3A4CYP2C19PIK3CD
SCHEMBL30036317 0.86 CYP1A2 (0.39) CYP1A2POLBCYP3A4CYP2C19PIK3CD
SCHEMBL29305266 0.86 CYP1A2 (0.39) CYP1A2POLBCYP3A4CYP2C19PIK3CD
SCHEMBL27159519 0.85 FFAR2 (0.37) PIK3CDSSTR4RIPK1ROCK2
SCHEMBL29305269 0.83 CYP1A2 (0.39) CYP1A2POLBCYP3A4CYP2C19PIK3CD
SCHEMBL30036762 0.83 CYP1A2 (0.39) CYP1A2POLBCYP3A4CYP2C19PIK3CD
SCHEMBL23070651 0.83 NTRK1 (0.45) CYP1A2POLBCYP3A4CYP2C19ROCK2
SCHEMBL29977249 0.83 NTRK1 (0.45) CYP1A2POLBCYP3A4CYP2C19ROCK2
SCHEMBL30480051 0.83 NTRK1 (0.45) CYP1A2POLBCYP3A4CYP2C19ROCK2
SCHEMBL23070666 0.83 NTRK1 (0.45) CYP1A2POLBCYP3A4CYP2C19ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4329766-A1 RIPK1 INHIBITORS AND METHODS OF USE Merck Sharp & Dohme LLC (US) 2024-03-06 — — EP disclosed
WO-2022231928-A1 RIPK1 INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME LLC (US) 2022-11-03 — — WO disclosed
Send feedback